Cabinet has agreed to use of the child version of the Pfizer vaccine to protect 5 to 11-years-olds. This decision was made with the advice from the COVID-19 Technical Advisory Group, and Medsafe's approval of both the safety and efficacy of the paediatric vaccine.

The vaccination of 5-11-year-olds started on 17 January. There are 476,000 children between ages 5-11 who became eligible to get their first dose from this date, and their second dose at least eight weeks later. 

You can access the course on our learning management system: Paediatric COVID-19 Vaccinator Education Course (Pfizer/BioNTech vaccine). You just need to log in.

Please find the resources below:

Vaccinating 5 to 11 year old Fact Sheet

Helping patients make informed decisions about vaccination of 5-11 year olds

IMAC Comparison - mRNA-CV (10 mcg) and mRNA-CV (30 mcg) version 3

IMAC Adult and Paediatric pre-vaccination screening and guidance version 9

IMAC PAEDIATRIC Pfizer BioNTech mRNA-CV 10ug Vaccine Preparation version 1

Management of Anaphylaxis All Ages

Tamariki support material Thanks to Auckland DHB for these. Aucklanders can get these materials from their DHB communications team, everyone else can print these out on A4 by downloading these resources here.

Tamariki certificate

I spy poster and colouring sheet

Activity sheet

Ministry of Health resources

COVID-19 vaccination and children

Information for parents and caregivers

Last updated: 19 January 2022